These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vaccines: more reasons to immunize. Consum Rep; 2006 Oct; 71(10):62. PubMed ID: 16981311 [No Abstract] [Full Text] [Related]
5. Live attenuated mumps virus vaccine. II. Early clinical studies. Stokes J; Weibel RE; Buynak EB; Hilleman MR Pediatrics; 1967 Mar; 39(3):363-71. PubMed ID: 6018966 [No Abstract] [Full Text] [Related]
6. Use of attenuated live mumps virus vaccine during a "virgin soil" epidemic of mumps on St. Paul Island, Alaska. Maynard JE; Shramek G; Noble GR; Deinhardt F; Clark P Am J Epidemiol; 1970 Nov; 92(5):301-6. PubMed ID: 5473777 [No Abstract] [Full Text] [Related]
8. Live mumps virus vaccine: clinical reactions and serological response in 615 children. Margileth AM; Mella GW; DiMoia F Med Ann Dist Columbia; 1968 Apr; 37(4):197-201. PubMed ID: 5239453 [No Abstract] [Full Text] [Related]
9. [Epidemiological studies in groups of persons immunized with mumps vaccine. I. Use of the vaccine in communities with a high epidemic potential]. Copelovici Y; Strati I; Strulovici D Stud Cercet Inframicrobiol; 1969; 20(1):3-10. PubMed ID: 5343651 [No Abstract] [Full Text] [Related]
10. Results of study of live antiparotitic vaccine and perspectives for the elimination of mumps as a mass infection. Kliachko NS; Shaposhnikova RP; Martysheva LN J Hyg Epidemiol Microbiol Immunol; 1967; 11(1):45-54. PubMed ID: 6070334 [No Abstract] [Full Text] [Related]
11. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme. Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C Microbios; 1996; 88(356):143-8. PubMed ID: 9141711 [TBL] [Abstract][Full Text] [Related]
12. Epidemiologic effectiveness of intradermal inoculation with live vaccine against epidemic parotitis (mumps). Raikhshtat GN; Shapiro AA; Karaseva MF; Leikina RF; Ryumina MG; Berlovich EA Fed Proc Transl Suppl; 1966; 25(5):827-8. PubMed ID: 5223567 [No Abstract] [Full Text] [Related]
13. Mumps virus vaccine. Med Lett Drugs Ther; 1968 Feb; 10(4):14-5. PubMed ID: 5637236 [No Abstract] [Full Text] [Related]
14. Studies on active immunization in measles, mumps and rubella. Stokes J Johns Hopkins Med J; 1967 Nov; 121(5):314-28. PubMed ID: 6075620 [No Abstract] [Full Text] [Related]
15. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003. Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK; Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204 [TBL] [Abstract][Full Text] [Related]
16. Vaccination against virus disease. Krugman S Maandschr Kindergeneeskd; 1968 Nov; 36(7):198-206. PubMed ID: 5715991 [No Abstract] [Full Text] [Related]
17. Vaccine against mumps. Br Med J; 1967 Jun; 2(5555):779-80. PubMed ID: 6029134 [No Abstract] [Full Text] [Related]
18. [Wide-spread inflammation of the parotid glands (mumps): an underestimated disease. II. Development, use, efficacy and safety of mumps vaccines]. Gałazka A; Kraigher A; Robertson SE Przegl Epidemiol; 1998; 52(4):401-12. PubMed ID: 10321084 [TBL] [Abstract][Full Text] [Related]
19. [Experience with increasing the immunogenic properties of live vaccine against epidemic parotitis]. Nasibov MN; Smorodintsev AA Vopr Virusol; 1968; 13(3):336-40. PubMed ID: 5749862 [No Abstract] [Full Text] [Related]
20. Epidemiology of mumps in Quebec, 1970-1995. De Serres G; Boulianne N; Bussières N; Pouliot B; Marin-Lira A Can Commun Dis Rep; 1997 Jan; 23(2):9-13. PubMed ID: 9136223 [No Abstract] [Full Text] [Related] [Next] [New Search]